Docusign Inc. $DOCU Shares Sold by Ameriprise Financial Inc.

Key Points

• Ameriprise Financial Inc. reduced its position in Docusign Inc. by 0.3%, owning approximately 1.18 million shares worth around $96.26 million as of the end of the most recent quarter.
• Docusign reported a quarterly EPS of $0.90, exceeding estimates and achieving a revenue of $763.65 million, a 7.6% increase year-over-year.
• A new share repurchase program was initiated, allowing Docusign to buy back up to $1 billion worth of its outstanding shares, indicating confidence in its current valuation.

Ameriprise Financial Inc. cut its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 0.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,182,504 shares of the company's stock after selling 3,602 shares during the period. Ameriprise Financial Inc. owned about 0.58% of Docusign worth $96,258,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. American Century Companies Inc. boosted its holdings in Docusign by 3.1% in the first quarter. American Century Companies Inc. now owns 5,477,758 shares of the company's stock valued at $445,890,000 after purchasing an additional 162,299 shares during the period. Jericho Capital Asset Management L.P. boosted its holdings in Docusign by 34.0% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after purchasing an additional 1,205,500 shares during the period. Northern Trust Corp boosted its holdings in Docusign by 77.2% in the fourth quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock valued at $178,475,000 after purchasing an additional 864,408 shares during the period. Wellington Management Group LLP boosted its holdings in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after purchasing an additional 1,440,269 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Docusign by 3.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company's stock valued at $153,780,000 after purchasing an additional 50,440 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on DOCU. Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a report on Friday, June 6th. Bank of America decreased their price target on Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Robert W. Baird decreased their price target on Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Morgan Stanley decreased their price target on Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, June 6th. Finally, Citigroup decreased their price target on Docusign from $115.00 to $110.00 and set a "buy" rating for the company in a report on Monday, June 9th. Four analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $89.77.

Insider Transactions at Docusign

In other news, CFO Blake Jeffrey Grayson sold 15,143 shares of the business's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the completion of the sale, the chief financial officer directly owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. The trade was a 12.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the sale, the chief executive officer directly owned 143,983 shares of the company's stock, valued at $11,160,122.33. The trade was a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,552 shares of company stock valued at $5,983,631 over the last quarter. Company insiders own 1.01% of the company's stock.

Docusign Trading Up 1.5%

Shares of Docusign stock traded up $1.15 on Friday, hitting $76.66. The stock had a trading volume of 2,272,539 shares, compared to its average volume of 2,322,855. Docusign Inc. has a 52-week low of $54.31 and a 52-week high of $107.86. The stock has a market cap of $15.49 billion, a price-to-earnings ratio of 14.49, a P/E/G ratio of 28.61 and a beta of 1.02. The company's 50 day moving average price is $75.41 and its 200 day moving average price is $79.67.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.09. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The business had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. During the same period in the previous year, the business earned $0.82 EPS. The business's quarterly revenue was up 7.6% on a year-over-year basis. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a stock buyback plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its stock is undervalued.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.